Comparison of Samples Obtained From 3.2% Sodium Citrate Glass and Two 3.2% Sodium Citrate Plastic Blood Collection Tubes Used in Coagulation Testing
|
|
- Nigel Dennis
- 5 years ago
- Views:
Transcription
1 Coagulation and Transfusion Medicine / GLASS VS PLASTIC IN HEMOSTASIS TESTING Comparison of Samples Obtained From 3.2% Sodium Citrate Glass and Two 3.2% Sodium Citrate Plastic Blood Collection Tubes Used in Coagulation Testing Robert C. Gosselin, CLS, 1 Kim Janatpour, MD, 1 Edward C. Larkin, MD, 1 Yanlap P. Lee, CLS, 1 and John T. Owings, MD 2 Key Words: Glass tubes; Plastic tubes; Coagulation testing Abstract We sought to compare coagulation test results obtained from patients using 2 plastic blood collection tubes and the traditional glass blood collection tube. Blood specimens were obtained from 241 patients in 3.2% buffered sodium citrate using standard glass tubes, in 3.2% buffered sodium citrate in plastic tubes, and in 3.2% sodium citrate sandwich tubes (plastic within plastic). All samples were obtained and processed contemporaneously and tested for prothrombin time (PT) and activated partial thromboplastin time (aptt). Residual plasma was frozen at 70 C for future testing, including fibrinogen, antithrombin, plasminogen, protein C and protein S (functional and antigenic), dilute Russell viper venom time (DRVVT), ristocetin cofactor, factor XIII, D dimer, anti-xa activity, and prothrombin fragment. Although paired t test analysis revealed statistically significant differences (P <.05) between glass and plastic for PT, aptt, fibrinogen, protein C (functional and antigenic), functional protein S, DRVVT and confirmation method, antithrombin, and factor XIII, these differences were not considered clinically significant. Traditionally, coagulation testing has been performed with specimens in 3.2% or 3.8% buffered sodium citrate in siliconized glass tubes. More recently, there has been increasing demand to collect blood in plastic tubes to avoid the inherent hazards associated with glass, including injuries due to broken glass and the risk of broken glass during centrifugation. Changes of blood collection tubes for coagulation testing always cause concern because of the potential for in vitro activation of the clotting cascade, with alteration of clotting times and various markers of clot activation and consumption. Therefore, we sought to compare 2 plastic blood collection tubes with traditional glass blood collection tubes to determine whether significant differences exist between glass and plastic blood collection tubes for routinely ordered coagulation studies. Materials and Methods After approval from our institutional review board, blood samples were obtained from a group of random outpatient and hospitalized patients using standard phlebotomy techniques. We prospectively obtained blood samples from 241 patients. For each patient, 3 additional tubes of blood were collected in a randomized manner: 3.2% buffered sodium citrate using standard glass Vacutainer tubes (Becton Dickinson, Franklin Lakes, NJ), 3.2% buffered sodium citrate in plastic Vacutainer tubes (Becton Dickinson), and 3.2% sodium citrate VACUETTE sandwich tubes (small 3.0-mL plastic tube within a larger -ml plastic tube; Grenier Bio-one, Monroe, NC). The outside of the Grenier tube is constructed of polyethylene terephthalate plastic, and the inner vacuum Downloaded from Am J Clin Pathol 2004;122:
2 Gosselin et al / GLASS VS PLASTIC IN HEMOSTASIS TESTING tube (hence sandwich ) containing the anticoagulant, is made of polypropylene plastic. Limited patient demographics, including sex, age, International Classification of Diseases, Ninth Revision codes, and medication history, were recorded. All blood samples were obtained and processed contemporaneously. Once processed, all samples were tested for prothrombin time (PT) using Innovin (Dade Behring, Deerfield, IL) and activated partial thromboplastin time (aptt) using Actin FS (Dade Behring). Residual plasma was frozen at 70 C for later testing Table 1, including Dade Behring methods for clottable fibrinogen (MultiFibrin U), chromogenic antithrombin activity (Berichrom), chromogenic plasminogen activity (Berichrom), clottable protein C activity, dilute Russell viper venom time (DRVVT) and confirmation method or DRVVT ratio (LA1 and LA2, respectively), ristocetin cofactor (BC von Willebrand reagent), chromogenic factor XIII (Berichrom), D dimer (Advanced D-Dimer), anti-xa activity (Berichrom), and prothrombin fragment (F1.2) using an enzyme-linked immunosorbent assay (ELISA) method (Enzygnost). Functional protein S was tested using StaClot Protein S (Diagnostica Stago, Parsippany, NJ). Antigenic protein C and protein S were tested using ELISA methods (Helena Laboratories, Beaumont, TX). Except for the ELISA methods, all coagulation testing was performed on the BCS analyzer (Dade Behring), and each test was measured concurrently on the plasma collected from the 3 blood collection tubes. Owing to increased costs associated with special coagulation testing, only selected patient samples were tested, which included normal samples and samples from patients with known pharmaceutical anticoagulation (oral vitamin K antagonist or heparin), patients after trauma or surgery, and hospitalized medical patients. The selection of patient samples for special coagulation testing was based on the potential of obtaining normal and abnormal (less or more than normal reference intervals) results for a given test. The Pearson correlation coefficient, Student paired t test, and repeated measures analysis of variance were used to compare results between collection tubes. A P value of less than.05 was considered statistically significant. Modified Bland- Altman style bias plots were generated to ascertain areas of bias between blood collection methods. Results All tests performed on samples obtained in plastic tubes correlated significantly with results obtained from glass tube samples (R > 0.92; P <.05). Paired t test analysis revealed statistically significant differences between blood collection methods and laboratory parameters Table 2. There were no statistically significant differences (P >.05) between glass and BD plastic or Grenier plastic tubes for D dimer, plasminogen activity, ristocetin cofactor, anti-xa activity, prothrombin fragment, or protein S antigen. There were statistically significant differences (P <.05) between blood collection tubes for PT, fibrinogen, and functional protein S, in addition with statistically significant differences between glass and both plastic collection methods for DRVVT, antithrombin, and factor XIII activity. In addition, there were significant differences (P <.05) between glass and BD plastic for aptt, protein C activity and antigen, and DRVVT confirmation ratio. There was no statistically significant difference between glass and Grenier plastic tubes for aptt results. There were no statistically significant differences between BD plastic and Grenier plastic tubes for D dimer, protein C function and antigen, DRVVT, DRVVT ratio, plasminogen, factor XIII, anti-xa activity, prothrombin fragment, or protein S antigen. Table 1 Reagent Description, Manufacturer, and Test Method Principle Test Manufacturer Test Method Principle PT Dade Behring, Deerfield, IL Recombinant tissue factor activation aptt Dade Behring Purified soy phosphatides with ellagic acid Fibrinogen Dade Behring Clotting: clottable fibrinogen D dimer Dade Behring Latex turbidimetric: using DD5 antibody Protein C activity Dade Behring Clotting: modified aptt after snake activation Protein C antigen Helena Laboratories, Beaumont, TX ELISA: antihuman protein C capture antibody Protein S activity Diagnostica Stago, Parsippany, NJ Clotting: modified aptt using activated protein C and factor Va reagents Protein S antigen Helena Laboratories ELISA: antihuman protein S capture antibody DRVVT and DRVVT ratio Dade Behring Clotting: Russell viper venom activation of factor X Antithrombin Dade Behring Chromogenic: thrombin substrate Plasminogen Dade Behring Chromogenic: streptokinase activation Factor XIII Dade Behring Chromogenic: NAD-NADH measurements Ristocetin cofactor Dade Behring Platelet agglutination method Anti-Xa Dade Behring Chromogenic: dextran sulfate and factor Xa Prothrombin fragment Dade Behring ELISA: rabbit antihuman F1.2 capture antibodies aptt, activated partial thromboplastin time; DD5, D dimer 5; DRVVT, dilute Russell viper venom time; ELISA, enzyme-linked immunosorbent assay; NAD, nicotinamide adenine dinucleotide; NADH, reduced form of NAD; PT, prothrombin time. 844 Am J Clin Pathol 2004;122: Downloaded 844 from
3 Coagulation and Transfusion Medicine / ORIGINAL ARTICLE Table 2 Data Analysis Comparing Coagulation Test Results Obtained From Glass and Plastic Collection Tubes * 3.2% BD Glass 3.2% BD Plastic 3.2% Grenier Plastic P P P PT (s) (n = 241) 9.3 ( ) 9.1 ( ) 9.2 ( ) <.001 <.001 <.001 aptt (s) (n = 241) 29.5 ( ) 28.7 ( ) 29.4 ( ) < <.001 Fibrinogen (mg/dl) (n = 112) ( ) ( ) ( ) < D dimer (mg/l) (n = 54) 2.50 ( ) 2.35 ( ) 2.60 ( ) Protein C (%NHP) (n = 51) 97.8 ( ) 97.0 ( ) 97.6 ( ) Protein S (%NHP) (n = 46) ( ) ( ) 99.0 ( ).038 < DRVVT (s) (n = 57) 38.8 ( ) 40.3 ( ) 41.9 ( ) <.001 < DRVVT confirmation ratio (n = 51) 1.20 ( ) 1.21 ( ) 1.22 ( ) Antithrombin (%NHP) (n = 73) 91.4 ( ) 89.8 ( ) 89.2 ( ).004 < Plasminogen (%NHP) (n = 43) ( ) ( ) ( ) Factor XIII (%NHP) (n = 30) 99.3 ( ) 99.5 ( ) 99.7 ( ) Ristocetin cofactor (%NHP) (n = 36) ( ) 98.5 ( ) ( ) Anti-Xa activity (U/mL) (n = 44) 0.24 (-1.29) 0.22 (-1.10) 0.21 (-1.29) Protein C antigen (%NHP) (n = 33) 94.4 ( ) 90.5 ( ) 89.1 ( ) < Protein S antigen (%NHP) (n = 25) ( ) 98.4 ( ) 98.3 ( ) Prothrombin fragment (nmol/l) 0.89 (8-3.3) 0.80 (8-2.93) 0.87 (7-2.91) (n = 34) aptt, activated partial thromboplastin time; NHP, normal human plasma; PT, prothrombin time; DRVVT, dilute Russell viper venom time. * Data are given as median (range). P values were determined by using the Student paired t test. For proprietary information, see the text. Comparison between BD glass and BD plastic tubes. Comparison between BD glass and Grenier Bio-one tubes. Comparison between BD plastic and Grenier Bio-one plastic tubes. By using a modified Bland-Altman style bias plot, we demonstrated that the majority of PT values were within 2.0 seconds Figure 1A. For aptts less than 50 seconds, the majority of samples demonstrated a less than -second bias Figure 1B. The spread of aptt differences became larger at more than 50 seconds. There was a general trend of increasing bias with increased levels of protein and peptide and increasing clotting times Figure 1C, Figure 1D, Figure 1E, Figure 1F, Figure 1G, Figure 1H, Figure 1I, Figure 1J, and Figure 1K. We compared anti-xa activities with corresponding aptts in a small population of patients receiving heparin therapy (n = 15). By using regression analysis of these data, we calculated the aptt range based on 0.3 to 0.7 U/mL of anti-xa activity of unfractionated heparin to be 50 to 65 seconds, 48 to 59 seconds, and 50 to 63 seconds for glass, BD plastic, and Grenier plastic tubes, respectively. Four patients enrolled in the study were receiving direct thrombin inhibitors (DTIs) at the time blood samples were obtained: lepirudin, 2 patients; bivalirudin, 1 patient; and argatroban, 1 patient. In these DTI samples, the aptt values obtained from Grenier plastic tubes had a higher bias compared with samples obtained in glass tubes. To determine whether this was an aberrant finding, we obtained a blood sample from a healthy person using prepared lepirudin syringes containing between 0.1 and 1.2 µg/ml of the drug. Once drawn, the whole blood was dispensed into the 3 blood collection tubes (glass, BD plastic, Grenier plastic) and processed as previously described. These samples were analyzed for aptt, which also demonstrated a positive bias with the Grenier plastic tubes Figure 2. Discussion We sought to determine whether conversion to plastic sodium citrate tubes for coagulation testing would result in significant differences in results. There have been a limited number of reports on the impact of plastic blood collection tubes on coagulation testing, which are primarily limited to PT testing. 1-3 Another report indicated statistically significant differences in stratified patient populations for PT, aptt, fibrinogen, prothrombin fragment, and activated factor XII but not for anti-xa activity using Terumo Medical (Somerset, NJ) glass and plastic blood collection systems. 4 More recently, Flanders and colleagues 5 reported a statistical difference in the thrombin time test but not in other clotting tests in a small series of healthy patients. In the present study, we compared coagulation testing using traditional 3.2% sodium citrate glass tubes and 2 available 3.2% sodium citrate plastic tubes, using 5 testing methods (clotting, chromogenic, immunoturbidimetric, ELISA, and aggregation methods) on 16 analytes. Because all samples were obtained, processed, and tested contemporaneously for any given test, any bias noted would have been a result of the collection method. We demonstrated that a number of results reported from samples collected in traditional glass tubes were significantly different from results obtained from samples collected in plastic collection tubes. Most test biases tended to increase with increasing clotting times or protein levels. The majority of the biases seen with PT were less than 2.0 seconds. The Grenier plastic tube samples tended to give higher aptt results than did the glass tubes, whereas results with the BD plastic tubes were lower than with the glass tubes. In general, the discrepancies in the absolute values for any analyte obtained from Downloaded from Am J Clin Pathol 2004;122:
4 Gosselin et al / GLASS VS PLASTIC IN HEMOSTASIS TESTING A B C Glass PT, s Glass aptt, s D ,150 Glass Fibrinogen, mg/dl Difference, mg/dl Glass Antithrombin, %NHP E F Glass Protein C, %NHP Glass Protein S, %NHP G H Glass DRVVT, s Difference, Ratio Glass DRVVT Ratio 846 Am J Clin Pathol 2004;122: Downloaded 846 from
5 Coagulation and Transfusion Medicine / ORIGINAL ARTICLE I J Glass Protein C Antigen, %NHP Glass Ristocetin Cofactor, %NHP K Glass Factor XIII, %NHP Figure 1 Modified Bland-Altman style bias plots comparing the observed difference between results of samples collected in 3.2% sodium citrate glass tubes with results from samples collected in 3.2% sodium citrate plastic tubes from Becton Dickinson (squares) and Grenier Bio-one (triangles). Only tests that yielded significant differences between glass and plastic tubes (Table 2 data) were plotted. Data are given in conventional units for fibrinogen and factor XIII; to convert to Système International units for fibrinogen (g/l), divide by 1; for factor XIII (proportion of 1.0), divide by 1. aptt, activated partial thromboplastin time; DRVVT, dilute Russell viper venom time; NHP, normal human plasma; PT, prothrombin time. For proprietary information, see the text. any blood collection method would not have resulted in a change in clinical decision or treatment and, therefore, were deemed clinically insignificant. The exceptions are the apparent biases noted with samples obtained in Grenier plastic tubes from patients receiving DTI therapy and the limitations to be described later. There was no effect of blood collection method on the immunoturbidimetric method of analysis (D dimer). There was no effect of blood collection tubes on chromogenic determination of heparin and plasminogen, but blood collection tubes did affect antithrombin and factor XIII activity testing, with the majority of results within 5% of normal human plasma. It is unclear why the antithrombin test, using thrombin substrate, or factor XIII activity would be affected by plastic blood collection methods, although it has been reported that a thrombin-based test (the thrombin time) was significantly dependent on collection method. 5 Because thrombin is a component in the antithrombin and factor XIII activity measurements used in the present study, there might be some effect in the thrombin generation pathway that might be affected by the type of collection tube. There are several limitations to this study. First, although all samples were obtained concurrently and improperly obtained samples (clotted and/or incomplete filling) ultimately Glass aptt, s Figure 2 Modified Bland-Altman style bias plots comparing the observed difference between results of samples collected in 3.2% sodium citrate glass tubes with results from samples collected in 3.2% sodium citrate plastic tubes from Becton Dickinson (squares) and Grenier Bio-one (triangles) in samples containing direct thrombin inhibitors (lepirudin, bivalirudin, or argatroban). aptt, activated partial thromboplastin time. For proprietary information, see the text. rejected, all blood samples were obtained using individual vacuum tubes. Therefore, subtle differences in tube blood volume, which would mimic clinical practice, might result in minor, clinically insignificant differences in the results. Downloaded from Am J Clin Pathol 2004;122:
6 Gosselin et al / GLASS VS PLASTIC IN HEMOSTASIS TESTING Second, when comparing samples from patients receiving heparin treatment, there were minor differences found in results from the 3 collection tubes. However, a limited number of heparin samples were tested (n = 15), and, therefore, further testing on samples obtained from patients receiving therapeutic heparin must be performed using the procedure described by Brill-Edwards and colleagues. 6 There also were a limited number of samples from patients receiving DTIs, and there seems to be a bias associated with Grenier plastic tubes. We tested samples obtained by in vitro anticoagulation before placement into blood collection tubes, but this might not accurately reflect in vivo drug response. In addition, because we tested any given patient only once during the duration of the study, it is unclear whether aptt ratios, which are the recommended target for DTI anticoagulation, would mitigate any collection bias seen with aptt testing. Conclusions There are statistically significant differences noted for coagulation testing of samples obtained in glass and plastic tubes. However, these differences are not clinically significant. As such, replacement of glass sodium citrate blood collection tubes with plastic sodium citrate blood collection tubes would be acceptable, with the following concerns: (1) We found some evidence that samples from patients treated with heparin or DTIs might be affected by collection method, and further evaluation in this area is necessary. (2) Because of the trending bias between plastic and blood collection tubes with increasing protein levels or clotting times, an adjustment to normal reference intervals might be warranted after reevaluating normal samples obtained in plastic tubes. From the Departments of 1 Pathology and 2 Surgery, University of California, Davis Medical Center, Sacramento. Address reprint requests to Dr Owings: UCDMC Trauma Division, Room 4209, 2315 Stockton Blvd, Sacramento, CA None of the investigators in this study has any conflict of interest with reagent or drug manufacturers. References 1. Tripodi A, Chantarangkul V, Bressi C, et al. How to evaluate the influence of blood collection systems on the international sensitivity index: protocol applied to two new evacuated tubes and eight coagulometer/thromboplastin combinations. Thromb Res. 2002;108: Ridyard J, Bhavnani M, Seal LH. Laboratory control of oral anticoagulant therapy: preservation of prothrombin time specimens using a polypropylene collection system. Clin Lab Haematol. 1998;20: D Angelo G, Villa C. Measurement of prothrombin time in patients on oral anticoagulant therapy: effect of two different evacuated tubes [letter]. Haematologica. 1999;84: Biron-Andreani C, Mallol C, Seguret F, et al. Plastic versus siliconized glass tubes: evaluation in current laboratory practice [letter]. Thromb Haemost. 2000;83: Flanders MM, Crist R, Rodgers GM. A comparison of blood collection in glass versus plastic Vacutainers on results of esoteric coagulation assays. Lab Med. 2003;34: Brill-Edwards P, Ginsberg JS, Johnston M, et al. Establishing a therapeutic range for heparin therapy. Ann Intern Med. 1993;119: Am J Clin Pathol 2004;122: Downloaded 848 from
Clinically Relevant Differences in Prothrombin Time and INR Values Related to Blood Sample Collection in Plastic vs Glass Tubes
Coagulation and Transfusion Medicine / PT/INR DIFFERENCES IN PLASTIC VS GLASS TUBES Clinically Relevant Differences in Prothrombin Time and INR Values Related to Blood Sample Collection in Plastic vs Glass
More informationClinically Relevant Differences in Prothrombin Time and INR Values Related to Blood Sample Collection in Plastic vs Glass Tubes
Coagulation and Transfusion Medicine / PT/INR DIFFERENCES IN PLASTIC VS GLASS TUBES Clinically Relevant Differences in Prothrombin Time and INR Values Related to Blood Sample Collection in Plastic vs Glass
More informationCoagulation and Transfusion Medicine
Coagulation and Transfusion Medicine / BLOOD COLLECTION TUBES AND PT Influence of Blood Collection Systems on the Prothrombin Time and International Sensitivity Index Determined With Human and Rabbit Thromboplastin
More informationCollection of Blood Specimens by Venipuncture for Plasma-Based Coagulation Assays Necessity of a Discard Tube
Coagulation and Transfusion Medicine / Discard Tube Unnecessary for Coagulation Assays Collection of Blood Specimens by Venipuncture for Plasma-Based Coagulation Assays Necessity of a Discard Tube Maarten
More informationComparison of Three Methods for Measuring Factor VIII Levels in Plasma
Coagulation and Transfusion Medicine / THREE FACTOR VIII ASSAYS Comparison of Three Methods for Measuring Factor VIII Levels in Plasma Wayne L. Chandler, MD, Chris Ferrell, MT(ASCP), Joo Lee, MT(ASCP),
More informationA Percent Correction Formula for Evaluation of Mixing Studies
Coagulation and Transfusion Medicine / A PERCENT CORRECTION FORMULA FOR EVALUATION OF MIXING STUDIES A Percent Correction Formula for Evaluation of Mixing Studies Sheng-hsiung Chang, MD, Veronica Tillema,
More informationWarfarin Does Not Interfere with Lupus Anticoagulant Detection by Dilute Russell s Viper Venom Time
Clin. Lab. 2009;55:XXX-XXX Copyright ORIGINAL ARTICLE Warfarin Does Not Interfere with Lupus Anticoagulant Detection by Dilute Russell s Viper Venom Time HORATIU OLTEANU 2, KATHARINE. A. DOWNES 1, JIGAR
More informationThe study has been approved by Ethics Commission. Informed consent has been given by all participants.
Evaluation of new 9NC Coagulation Tubes Background: Venous blood with sodium citrate is the most commonly obtained examination sample for coagulation determinations. The additive functions as an anticoagulant
More informationStability of prothrombin time and activated partial thromboplastin time tests under different storage conditions
Clinica Chimica Acta 300 (2000) 13 21 www.elsevier.com/ locate/ clinchim Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions L.V. Rao *, A.O.
More informationHEMOSTASIS Quality Time saving Economy Practicability Quality assurance Precision
Quality Time saving Economy Practicability Quality assurance Precision exclusive distributor of for France, Netherlands, Belgium and Luxembourg List of frozen reagents In 1992, Precision BioLogic began
More informationEARLY ONLINE RELEASE
EARLY ONLINE RELEASE Note: This article was posted on the Archives Web site as an Early Online Release. Early Online Release articles have been peer reviewed, copyedited, and reviewed by the authors. Additional
More informationY. ZHAO, G. LV SUMMARY
International Journal of Laboratory Hematology ORIGINAL ARTICLE The Official journal of the International Society for Laboratory Hematology INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY Influence of temperature
More informationPICT ANTICOAGULANT MONITORING 1. PEFAKIT PICT. Clotting Assay. PEFAKIT PiCT. PEFAKIT PICT Calibrators UFH. PEFAKIT PICT Controls UFH
1 2 3 4 PEFAKIT PiCT PEFAKIT PICT Calibrators UFH PEFAKIT PICT Controls UFH PEFAKIT PICT Calibrators LMWH Clotting Assay PICT 1. PEFAKIT PICT Package size 8-505-01 kit 80 3 vials of PiCT Activator (2mL)
More informationInternal Quality Control in the Haemostasis laboratory. Dr Steve Kitchen Sheffield Haemophilia and Thrombosis centre & UK NEQAS Blood Coagulation
Internal Quality Control in the Haemostasis laboratory Dr Steve Kitchen Sheffield Haemophilia and Thrombosis centre & UK NEQAS Blood Coagulation Why do we need Quality control? Philadelphia Enquirer Aug
More informationEDUCATIONAL COMMENTARY DISSEMINATED INTRAVASCULAR COAGULATION
EDUCATIONAL COMMENTARY DISSEMINATED INTRAVASCULAR COAGULATION Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE
More informationLupus Anticoagulants (LA), Antiphospholipid (APL) Antibodies & APL Syndrome: Review & Update. Antiphospholipid. Antiphospholipid
, Antiphospholipid (APL) Antibodies & APL Syndrome: Review & Update William L. Nichols, MD Mayo Clinic College of Medicine Rochester, Minnesota USA Disclosures & Objectives (Nichols) Disclosures Relevant
More informationACTICLOT dpt REF 824. IVD C i 2 l. Dilute Prothrombin Time Test for the Determination of Lupus Anticoagulants (LA) (CPT Code No.
Sekisui Diagnostics, LLC 500 West Avenue, Stamford, CT 06902 M Tel. (203) 602-7777 Fax (203) 602-2221 INTENDED USE The ACTICLOT dpt is intended for the qualitative determination of Lupus Anticoagulants
More informationADMINISTRATIVE CLINICAL Page 1 of 6
ADMINISTRATIVE CLINICAL Page 1 of 6 Anticoagulant Guidelines #2: REVERSAL OF OR MANAGEMENT OF BLEEDING WITH ANTICOAGULANTS Origination Date: Revision Date: Reviewed Date: 09/12 09/12, 01/13, 11/13, 11/15
More informationIntroduction to coagulation and laboratory tests
Introduction to coagulation and laboratory tests Marc Jacquemin Special Haemostasis Laboratory Center for Molecular and Vascular Biology University of Leuven Coagulation in a blood vessel: fibrin stabilises
More informationBlood clotting. Subsequent covalent cross-linking of fibrin by a transglutaminase (factor XIII) further stabilizes the thrombus.
Blood clotting It is the conversion, catalyzed by thrombin, of the soluble plasma protein fibrinogen (factor I) into polymeric fibrin, which is deposited as a fibrous network in the primary thrombus. Thrombin
More informationL iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche
L iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche Armando Tripodi Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Dept. of Clinical Sciences and Community Health University
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/37409 holds various files of this Leiden University dissertation Author: Engbers, Marissa Title: Conventional and age-specific risk factors for venous thrombosis
More informationElevated Factor XI Activity Levels Are Associated With an Increased Odds Ratio for Cerebrovascular Events
Coagulation and Transfusion Medicine / FACTOR XI AND RISK OF STROKE Elevated Factor XI Activity Levels Are Associated With an Increased Odds Ratio for Cerebrovascular Events David T. Yang, MD, 1 Michele
More informationVitamin K antagonist (VKA) therapy is routinely
International Normalized Ratio Versus Plasma Levels of Coagulation Factors in Patients on Vitamin K Antagonist Therapy Gene Gulati, PhD; Megan Hevelow, MS; Melissa George, DO; Eric Behling, MD; Jamie Siegel,
More informationBlood Collection Additives
Blood Collection Additives Blood collection tubes and other collection devices often contain one or more additives. There are a number of different types of additives, and each has a specific function.
More informationInstruments smart solutions & service IGZ Instruments AG Räffelstrasse 32 CH 8045 Zürich
ADP (Adenosine-5 -Diphosphate) 101312 3 x 0.5mL ADP is a lyophilized preparation of adenosine-5 -diphosphate. The working concentration of the reconstituted reagent is 2 x 10-4 M. ADP is for use in routine
More informationWorldwide Report Coagulation Lot Exp 31 Oct 2018
April 0 Worldwide Report Coagulation Lot 780 Exp Oct 08 Activated Partial Thromboplastin Time (APTT) Diagnostica Stago C.K. Prest Seconds 0.7 0.89.8 9 0.7 0.89.8 9 8.8..7 8.8..7 9.90 0.97.0 9.90 0.97.0
More informationPart IV Antithrombotics, Anticoagulants and Fibrinolytics
Part IV Antithrombotics, Anticoagulants and Fibrinolytics "The meaning of good and bad, of better and worse, is simply helping or hurting" Emerson Chapter 16: Blood Coagulation and Fibrinolytic System
More informationChristopher M. Lehman, MD, 1,3 Lori W. Wilson, MT(ASCP), MS, 3 and George M. Rodgers, MD, PhD 1-3. Abstract
Coagulation and Transfusion Medicine / D-DIMER FOR THE DIAGNOSIS OF DIC Analytic Validation and Clinical Evaluation of the STA LIATEST Immunoturbidimetric D-Dimer Assay for the Diagnosis of Disseminated
More informationOptimal Utilization of Thrombophilia Testing
Optimal Utilization of Thrombophilia Testing Rajiv K. Pruthi, MBBS Special Coagulation Laboratory & Comprehensive Hemophilia Center Division of Hematology/Internal Medicine Dept of Laboratory Medicine
More informationPlease note that the uses described in the following page(s) have not been approved or cleared by FDA, with respect to the described assay or test.
Please note that the uses described in the following page(s) have not been approved or cleared by FDA, with respect to the described assay or test. In the US, the product is intended For Research Use Only.
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK University Hospitals NHS Foundation Trust Haematology and Transfusion Department Mindelsohn Way Edgbaston Contact: Tel: +44 (0) 121 371 5963
More informationAntiphospholipid antibodies in patients with venous thrombosis at Kenyatta National Hospital
Research article Department of Human Pathology, School of Medicine, University of Nairobi, P. O. Box 19676 00202, Nairobi, Kenya Corresponding author: Dr KA Barasa, Department of Human Pathology, School
More informationEvaluation Report. Eurolyser PT (INR) test kit (ST0180) on CUBE and smart analysers
Evaluation Report Eurolyser PT test kit (ST0180) on CUBE and smart analysers Locations Location 1: Eurolyser Diagnostica GmbH Operator: Simone Wieser Date: 30.06.2015 Specimens The specimens used for analysis
More informationThe LaboratoryMatters
Laboratory Medicine Newsletter for clinicians, pathologists & clinical laboratory technologists. A Initiative. HEMOSTASIS AND THE LABORATORY This issue highlights: Primary Hemostasis Screening Tests Case
More informationM B Garvey. University of Toronto
Do I really need that test??? M B Garvey Professor Emeritus University of Toronto St Michael s Hospital No relevant conflicts of interest 1 HEMOSTASIS IS LIKE LOVE Everybody talks about it, nobody understands
More informationPrimary Exam Physiology lecture 5. Haemostasis
Primary Exam Physiology lecture 5 Haemostasis Haemostasis Body s response for the prevention and cessation of bleeding. Broadly consists of: Primary Haemostasis - vascular spasm and platlet plug formation
More informationQuickVet Diagnostic System
QuickVet Diagnostic System Package insert for QuickVet PT/aPTT Coag Combo Test Version: January 4, 2017 Introduction The QuickVet PT/aPTT Coag Combo test cartridge is a quantitative coagulation test intended
More informationInsights on the Quality of Coagulation Testing
Insights on the Quality of Coagulation Testing Piet Meijer ECAT Foundation The Netherlands No conflicts of interest HAEMOSTATIC BALANCE BLEEDING HAEMOSTATIC BALANCE THROMBOSIS HAEMOSTATIC BALANCE Thrombosis
More informationBlood coagulation and fibrinolysis. Blood clotting (HAP unit 5 th )
Blood coagulation and fibrinolysis Blood clotting (HAP unit 5 th ) Vessel injury Antithrombogenic (Favors fluid blood) Thrombogenic (Favors clotting) 3 Major systems involved Vessel wall Endothelium ECM
More informationCauses of isolated prolonged activated partial thromboplastin time in an acute care general hospital
O r i g i n a l A r t i c l e Singapore Med J 2005; 46(9) : 450 Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital W J Chng, C Sum, P Kuperan Department
More informationUse of PSI on CS instruments
Johan Claes, Version 01, 1 st September 2016 User day hemostasis 2016 Use of PSI on CS instruments Restricted Siemens Healthcare GmbH, 2016 Hemostasis Lab Challenges Preanalytical problems in Haemostasis
More informationChapter 19. Hemostasis
Chapter 19 Hemostasis Hemostasis Hemostasis is the cessation of bleeding stopping potentially fatal leaks important in small blood vessels not effective in hemorrhage excessive bleeding from large blood
More informationHistory of the Vacutainer Tube. Coagulant Blood Tests
History of the Vacutainer Tube The different tubes are known as a vacutainer and were developed by Joseph Kleiner in 1947. The vacutainer is currently being manufactured by Becton, Dickinson and Company
More informationprevent its recurrence. The FDA is reviewing possible deficiencies in the manufacturer s reagent package labeling.
science [coagulation and hematology] Laboratory Variables That May Affect Test Results in Prothrombin Times (PT)/International Normalized Ratios (INR) David L. McGlasson, MS, CLS/NCA, H, ASCP 59th Clinical
More informationHemostasis and. Blood Coagulation
Hemostasis and Blood Coagulation Events in Hemostasis The term hemostasis means prevention of blood loss. Whenever a vessel is severed or ruptured, hemostasis is achieved by several mechanisms: (1) vascular
More informationUse of PSI on CS instruments
Johan Claes, Version 01, 1 st September 2016 User day hemostasis 2016 Use of PSI on CS instruments Restricted Siemens Healthcare GmbH, 2016 Hemostasis Lab Challenges Preanalytical problems in Haemostasis
More informationMohammadreza Tabatabaei IBTO COAG LAB
Tests for the Evaluation of Lupus Anticoagulants t Mohammadreza Tabatabaei MSc Hematology blood bank MSc Hematology blood bank IBTO COAG LAB Lupus Anticoagulants General Background Lupus anticoagulants
More informationCLINICAL FELLOWSHIP PROGRAM IN COAGULATION
CLINICAL FELLOWSHIP PROGRAM IN COAGULATION The Department of Pathology and Laboratory Medicine University of Alberta, Faculty of Medicine and Dentistry and Alberta Health Services CLINICAL FELLOWSHIP IN
More informationOral Factor Xa Inhibitors and Clinical Laboratory Monitoring
Oral Factor Xa Inhibitors and Clinical Laboratory Monitoring MELISSA L. WHITE ABSTRACT Oral anticoagulation therapy is currently undergoing great changes with the development and use of several new medications.
More informationProthrombin (Human) ELISA Kit
Prothrombin (Human) ELISA Kit Catalog Number KA0496 96 assays Version: 04 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 Principle of the Assay... 3 General
More informationThis slide belongs to iron lecture and it is to clarify the iron cycle in the body and the effect of hypoxia on erythropoitein secretion
This slide belongs to iron lecture and it is to clarify the iron cycle in the body and the effect of hypoxia on erythropoitein secretion Topics of today lectures: Hemostasis Meaning of hemostasis Mechanisms
More informationCharacterisation of Direct Acting Oral Anticoagulants and Their Pharmacodynamics on Thrombin Generation and Coagulation Parameters.
Characterisation of Direct Acting Oral Anticoagulants and Their Pharmacodynamics on Thrombin Generation and Coagulation Parameters. Matthew Halliday Bachelor of Science in Biomedical Science, Forensics
More informationIndividual Lab Report Ci-Trol Nov,2016. Abnormal Fibrinogen (mg/dl) Abnormal Fbg Control - Lot# LFC Your Lab
Individual Lab Report Ci-Trol Nov,2016 ST VINCENT MEDICAL CENTER LABORATORY(LAB# 7300 ) 2131 WEST THIRD STREET LOS ANGELES CA USA 90057 Abnormal Fibrinogen (mg/dl) Abnormal Fbg Control - Lot# LFC SYSMEX
More informationHemostasis. Learning objectives Dr. Mária Dux. Components: blood vessel wall thrombocytes (platelets) plasma proteins
Hemostasis Learning objectives 14-16 Dr. Mária Dux Components: blood vessel wall thrombocytes (platelets) plasma proteins Hemostatic balance! procoagulating activity anticoagulating activity 1 Thrombocytes
More informationFIGURE 1. Coagulation cascade. a = activated factor; Ca = calcium; PL = phospholipid. Adapted from Biochemistry, 2 with permission from American Chemi
CONCISE REVIEW FOR CLINICIANS PROLONGED PT AND APTT How to Interpret and Pursue an Abnormal Prothrombin Time, Activated Partial Thromboplastin Time, and Bleeding Time in Adults ARIF H. KAMAL, MD; AYALEW
More informationHEMOCHRON. Whole Blood Coagulation Systems
HEMOCHRON Whole Blood Coagulation Systems Citrated Activated Partial Thromboplastin Time (APTT) Cuvette Correlation Protocol for HEMOCHRON Microcoagulation Instruments MSIG:131 10/06 Dear Medical Professional:
More informationHow Good is your INR? The Use of Certified Plasmas in PT/INR Testing. INR System. How Good is your INR? Outline
How Good is your INR? The Use of Certified Plasmas in PT/INR Testing Dot Adcock, MD Esoterix Coagulation Mayo/NASCOLA Coagulation Testing Quality Conference April 25, 2007 How Good is your INR? The Use
More information^ J a n e t K a l l o. ^ J u n e CLINICAL UTILITY OF PLASMA PROTEIN C MEASUREMENT
^ J a n e t K a l l o ^ J u n e 1 9 8 8 CLINICAL UTILITY OF PLASMA PROTEIN C MEASUREMENT TEST Plasma protein C, antigenic and functional activity measurement BACKGROUND Protein C is one of several known
More informationProtein C and protein S levels can be accurately determined within 24 hours of diagnosis of acute venous thromboembolism
Clin. Lab. Haem. 2006, 28, 9 13 M. J. KOVACS*, J. KOVACS*, J. ANDERSON, M. A. RODGER, K. MACKINNON, P. S. WELLS Summary Keywords Protein C and protein S levels can be accurately determined within 24 hours
More informationACQUIRED COAGULATION ABNORMALITIES
ACQUIRED COAGULATION ABNORMALITIES ACQUIRED COAGULATION ABNORMALITIES - causes 1. Liver disease 2. Vitamin K deficiency 3. Increased consumption of the clotting factors (disseminated intravascular coagulation
More informationIl laboratorio: verso una migliore definizione dei test
Il laboratorio: verso una migliore definizione dei test Armando Tripodi Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Dept. of Clinical Sciences and Community Health University of Milano Laboratory
More informationHEMATOLOGY AND COAGULATION ANALYTIC PROTOCOLS
1 of 6 Policy #: 800 (PLH-800-13) Initiated Date: 12/4/2002 Reviewed Date: 8/1/2016 Subject: HEMATOLOGY AND COAGULATION ANALYTIC PROTOCOLS Approved by: Laboratory Director, Jerry Barker (electronic signature)
More informationTUD Sdn Bhd ( V)
Instruction for Use of TUD Evacuated Blood Collection Tubes Direction for Use of TUD Evacuated Blood Collection Tube Product name: TUD Evacuated blood collection tube I. Application: It is used for collection,
More informationNOACS/DOACS*: COAGULATION TESTS
NOACS/DOACS*: COAGULATION TESTS OBJECTIVES: To describe the effect of the newer direct oral anticoagulants (DOACs) on laboratory coagulation tests which are widely available: prothrombin time (PT), international
More informationReferrals for abnormal coagulation profiles are common
A Practical Approach to Pediatric Patients Referred With an Abnormal Coagulation Profile Monica Acosta, MD; Rachel Edwards, BS; E. Ian Jaffe, MD; Donald L. Yee, MD; Donald H. Mahoney, MD; Jun Teruya, MD,
More informationReversal of Anticoagulants at UCDMC
Reversal of Anticoagulants at UCDMC Introduction: Bleeding complications are a common concern with the use of anticoagulant agents. In selected situations, reversing or neutralizing the effects of an anticoagulant
More informationBlood Thinner Agent. Done by: Meznah Al-mutairi Pharm.D Candidate PNU Collage of Pharmacy
Blood Thinner Agent Done by: Meznah Al-mutairi Pharm.D Candidate PNU Collage of Pharmacy Outline: Blood thinner agent definition. anticoagulants drugs. Thrombolytics. Blood thinner agent Therapeutic interference
More informationDiagnosis of hypercoagulability is by. Molecular markers
Agenda limitations of clinical laboratories to evaluate hypercoagulability and the underlying cause for thrombosis what is the INR the lupus anticoagulant and the antiphospholipid antibody syndrome hassouna
More informationMEASUREMENT OF ANTICOAGULANT EFFECTS OF NEW ORAL ANTICOAGULANTS PRACTICAL ASPECTS
MEASUREMENT OF ANTICOAGULANT EFFECTS OF NEW ORAL ANTICOAGULANTS PRACTICAL ASPECTS Désirée Coen Herak Department of Laboratory Diagnostics University Hospital Centre Zagreb WARFARIN ERA Warfarin monopoly
More informationby accumulation of pathological mast cells in potentially any or all organs and tissues and/or
1 Supplementary Material to Seidel et al. Bleeding diathesis in patients with mast cell activation disease (Thromb Haemost 2011; 106.5) Definition of mast cell activation disease The term mast cell activation
More informationLaboratory monitoring of oral anticoagulants. A/Prof. Lee Lai Heng Haematology Singapore General Hospital
Laboratory monitoring of oral anticoagulants A/Prof. Lee Lai Heng Haematology Singapore General Hospital Relevant Disclosures Educational and Travel Grants Bayer, Leo, Bristol Meyer Squib Advisory Boards
More informationA Novel Clotting Assay for Quantitation of Plasma Prothrombin (Factor II) Using Echis multisquamatus Venom
Coagulation and Transfusion Medicine VENOM-BSED PROTHROMBN SSY Novel Clotting ssay for Quantitation of Plasma Prothrombin (Factor ) Using Echis multisquamatus Venom Ramona]. Petrovan, PhD, Samuel. Rapaport,
More informationlaboratory monitoring of Direct Oral Anticoagulant: who, when and how Dr. Malake Naboulsi Hôpital Albert Haykel Laboratoire d hématologie.
laboratory monitoring of Direct Oral Anticoagulant: who, when and how Dr. Malake Naboulsi Hôpital Albert Haykel Laboratoire d hématologie. Disclosures Malake Naboulsi declare to meeting attendees that
More informationMultiple studies are available concerning the use of
SPECIAL ARTICLE Evaluation of the Biosite Ò Quantitative Whole Blood D-dimer Assay and Comparison With the biomérieux VIDAS Ò D-dimer Exclusion Test Validation and Utility For Use in the Central Laboratory
More informationThrombosis. Clinical Chemistry 51: (2005) Hemostasis and
Clinical Chemistry 51:3 561 568 (2005) Hemostasis and Thrombosis Preanalytical Variables and Off-Site Blood Collection: Influences on the Results of the Prothrombin Time/International Normalized Ratio
More informationMouse C-Peptide ELISA Kit
Mouse C-Peptide ELISA Kit Cat.No: DEIA4507 Lot. No. (See product label) Size 96T Intended Use The Mouse C-Peptide ELISA kit is for the quantitative determination of c-peptide in mouse serum, plasma, and
More informationClinical Study Procoagulant and Anticoagulant Factors in Childhood Hypothyroidism
International Endocrinology Volume 2012, Article ID 156854, 4 pages doi:10.1155/2012/156854 Clinical Study Procoagulant and Anticoagulant Factors in Childhood Hypothyroidism Nevin Kilic, 1 Yildiz Dallar,
More informationReceived 29 June 2005; received in revised form 17 October 2005; accepted 5 November 2005 Available online 19 January 2006
Thrombosis Research (2007) 119, 135 143 intl.elsevierhealth.com/journals/thre REGULR RTILE new plastic collection tube made of polyethylene terephtalate is suitable for monitoring traditional anticoagulant
More informationFresh and Citrated Whole-Blood Specimens Can Produce Different Thromboelastography Results in Patients on Extracorporeal Membrane Oxygenation
Fresh and Citrated Whole-Blood Specimens Can Produce Different Thromboelastography Results in Patients on Extracorporeal Membrane Oxygenation Elizabeth A. Gilman, MD, 1 Christopher D. Koch, 1 Paula J.
More informationUNIT VI. Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav. Copyright 2011 by Saunders, an imprint of Elsevier Inc.
UNIT VI Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav Hemostasis: Prevention of Blood Loss Vascular constriction Formation of a platelet plug Formation of a blood
More information10/24/2013. Heparin-Induced Thrombocytopenia (HIT) Anticoagulation Management in ECMO Therapy:
Anticoagulation Management in ECMO Therapy: Heparin-Induced (HIT) Michael H. Creer, MD Professor of Pathology Director, Clinical Laboratories, Medical Co- Director, Hematopathology and Chief, Division
More informationImproved Distinction of Factor V Wild-Type and Factor V Leiden Using a Novel Prothrombin-Based Activated Protein C Resistance Assay
Coagulation and Transfusion Medicine / A NOVEL PROTHROMBIN-BASED APC-R ASSAY Improved Distinction of Factor V Wild-Type and Factor V Leiden Using a Novel Prothrombin-Based Activated Protein C Resistance
More informationGenerate Knowledge Pre-Analytical Variables in the Coagulation Lab: Why Does It Matter?
Generate Knowledge Pre-Analytical Variables in the Coagulation Lab: Why Does It Matter? Paul Riley, PhD, MBA Pre-Analytical Variables: Objectives 1. Define Pre-Analytical variables 2. Explain how blood
More informationHAEMATOLOGY INTRODUCTION
HAEMATOLOGY INTRODUCTION Haematology Laboratory offers a comprehensive range of routine and specialised haematological investigations. The laboratory also offers Routine Urine Sediment Microscopy and molecular
More informationP re-analytical conditions are very important in laboratory assessment of hemostatic and coagulation systems
OPEN SUBJECT AREAS: PRE-CLINICAL STUDIES PROTEASES BIOCHEMICAL ASSAYS BIOPHYSICAL CHEMISTRY Received 19 November 2013 Accepted 8 January 2014 Published 27 January 2014 Correspondence and requests for materials
More informationKoostas: Anneli Aus Laboriarst Allkiri Ees- ja perekonnanimi Ametikoht kuupäev
Kinnitas: Elektroonselt Katrin Reimand Osakonnajuhataja 05.07.2017 kinnitatud Koostas: Anneli Aus Laboriarst 05.07.2017 Allkiri Ees- ja perekonnanimi Ametikoht kuupäev Haematology reference values Analyte
More informationProthrombin Complex Concentrate- Octaplex. Octaplex
Prothrombin Complex Concentrate- Concentrated Factors Prothrombin Complex Concentrate (PCC) 3- factor (factor II, IX, X) 4-factor (factors II, VII, IX, X) Activated 4-factor (factors II, VIIa, IX, X) Coagulation
More informationConsultative Coagulation How to Effectively Answer Common Questions About Hemostasis Testing Session #5000
Consultative Coagulation How to Effectively Answer Common Questions About Hemostasis Testing Session #5000 Dorothy M. (Adcock) Funk, M.D. Karen A. Moser, M.D. Esoterix Coagulation September 20, 2013 Disclosures
More informationThe effect of the direct oral anticoagulants (DOACs) on haemostasis tests.
The effect of the direct oral anticoagulants (DOACs) on haemostasis tests. Emmanuel J Favaloro, Haematology, ICPMR, Pathology West, Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital (with
More informationPart II: Coagulation Laboratory: Methods, Standards & Cost Effective Testing. Donna D. Castellone ASCP Annual Meeting
Part II: Coagulation Laboratory: Methods, Standards & Cost Effective Testing Donna D. Castellone Understanding Coagulation Case Studies - clinical picture - analysis - diagnosis Case Study A 15 yr old
More informationCTAD as a universal anticoagulant
Automated Methods & Management in Chemistry Vol. 25, No. 1 (January February 2003) pp. 17 20 CTAD as a universal anticoagulant M. Yokota, N. Tatsumi*, I. Tsuda, T. Nishioka and T. Takubo Department of
More informationJohn Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne
John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne Overview of coagulation Testing coagulation Coagulopathy in ICU Incidence Causes Evaluation Management Coagulation
More informationHematology Review. CCRN exam. The Coagulation Cascade. The Coagulation Cascade. Components include: Intrinsic pathway Extrinsic pathway Common pathway
CCRN exam Hematology Review CCRN Review October 2013 Department of Critical Care Nursing Hematology is 2% of the exam Focus on coagulation cascade, DIC, and HIT Anatomy of the hematologic system Bone marrow
More informationCoagulation, Haemostasis and interpretation of Coagulation tests
Coagulation, Haemostasis and interpretation of Coagulation tests Learning Outcomes Indicate the normal ranges for routine clotting screen and explain what each measurement means Recognise how to detect
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
Laboratory locations: 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Blood Sciences Pathology Building Hull Royal Infirmary Anlaby Road Hull HU3 2JZ Contact: Dr Andrew Botham Tel: +44 (0)1482
More informationHemolyzed Samples Should be Processed for Coagulation Studies: The Study of Hemolysis Effects on Coagulation Parameters
Original Article Hemolyzed Samples Should be Processed for Coagulation Studies: The Study of Hemolysis Effects on Coagulation Parameters Arora S, Kolte S, Dhupia JS Department of Pathology, VMMC and Safdarjang
More informationTopics of today lectures: Hemostasis
Topics of today lectures: Hemostasis Meaning of hemostasis Mechanisms of hemostasis - Vascular contraction - Platelets plug - Blood coagulation (clotting) - Structure and functions of platelets - Blood
More informationPotential Laboratory Misdiagnosis of Hemophilia and von Willebrand Disorder Owing to Cold Activation of Blood Samples for Testing
Coagulation and Transfusion Medicine / MISDIAGNOSIS OF VON WILLEBRAND DISORDER AND HEMOPHILIA Potential Laboratory Misdiagnosis of Hemophilia and von Willebrand Disorder Owing to Cold Activation of Blood
More informationCompositional Differences in Commercially Available Prothrombin Complex Concentrates
Original Article Compositional Differences in Commercially Available Prothrombin Complex Concentrates Clinical and Applied Thrombosis/Hemostasis 2014, Vol. 20(3) 256-269 ª The Author(s) 2013 Reprints and
More information